1Parkin DM, Bray F. The burden of HPV related cancers [ J ]. Vaccine, 2006,243 : 11-25.
2Pankin DM,Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990 [ J]. Int J Cancer, 1999,6 : 225 -231.
3Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papilloma virus and cervical cancer [ J ]. J Clin Pathol, 2002,55 (4): 244-265.
4zur Hausen H. Cervical carcinoma and human papillomavirus : on the road to preventing amaj or human cancer [ J ]. J Nat Cancer Inst, 2001, 93 (4) : 252-253.
5Steenbergen RDM, De wilde J, Wilting SM, et al. HPV mediated transformation of the anogenital tract [ J]. J Clin Virol,2005,32 ( 1 ) :S25-S33.
6Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) Llvirus-like particle vaccine in young women : a randomized double-blind placebo-controlled multicentre phase Ⅱ efficacy trial [ J ]. Lancet Oneol, 2005, 6(5):271-278.
9Amo T,Kawanishi N,Uehide M,et al.Mechanism of cell death by 5-aminolevulinic acid-based photodynamic action and its enhancement by ferrrochelalase inhibitors in human histiocytic lymphoma cell line U937.Cell Biochem Funet,2009,27(8):503-515.
10Ji HT,Chien LT,Lin YH,et al.5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-activated protein kinase.Mol Cancer,2010,28(9):91.
